These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3001897)

  • 1. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of HTLV-III antibodies using ELISA and the western blot].
    Kunz C; Heinz FX
    Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of commercial equipment used in blood banks in Córdoba for the detection of anti-HTLV-I/II antibodies].
    Llop N; Gastaldello R; Valle M; Macedo R; Maturano E; Blanco S; Medeot S; Gallego S
    Rev Argent Microbiol; 2000; 32(4):202-5. PubMed ID: 11149153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New evaluation of 3 immunoenzyme assay kits for the detection of anti-LAV antibodies].
    Rev Fr Transfus Immunohematol; 1986 Apr; 29(2):97-100. PubMed ID: 3018900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wellcozyme: a new kit for the detection of anti-HIV antibodies. Considerations apropos of the initial trials].
    North ML; Dominski J; Laustriat D
    Rev Fr Transfus Immunohematol; 1986; 29(5):311-22. PubMed ID: 3646731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
    Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rational microanalysis technic in the detection of antibodies to HTLV-III, CMV and EBV with indirect immunofluorescence].
    Stöcker W; Geusendam G; Schmitz H; Mohr H; Berndt H
    Beitr Infusionther Klin Ernahr; 1986; 15():51-7. PubMed ID: 3019301
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 20. HTLV-III antibody testing in three Danish blood banks.
    Orskov Lindhardt B; Ulrich K; Ryder L; Dickmeiss E; Sørensen H; Jørgensen J; Jersild C; Grunnet N
    Vox Sang; 1986; 51 Suppl 1():9-14. PubMed ID: 3017006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.